273 related articles for article (PubMed ID: 22117627)
1. Histo-blood group gene polymorphisms as potential genetic modifiers of the development of coronary artery lesions in patients with Kawasaki disease.
Yamamura K; Ihara K; Ikeda K; Nagata H; Mizuno Y; Hara T
Int J Immunogenet; 2012 Apr; 39(2):119-25. PubMed ID: 22117627
[TBL] [Abstract][Full Text] [Related]
2. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.
Nishimura S; Zaitsu M; Hara M; Yokota G; Watanabe M; Ueda Y; Imayoshi M; Ishii E; Tasaki H; Hamasaki Y
J Pediatr; 2003 Sep; 143(3):357-62. PubMed ID: 14517520
[TBL] [Abstract][Full Text] [Related]
3. Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease.
Kariyazono H; Ohno T; Khajoee V; Ihara K; Kusuhara K; Kinukawa N; Mizuno Y; Hara T
Pediatr Res; 2004 Dec; 56(6):953-9. PubMed ID: 15470196
[TBL] [Abstract][Full Text] [Related]
4. Association of COL11A2 polymorphism with susceptibility to Kawasaki disease and development of coronary artery lesions.
Sheu JJ; Lin YJ; Chang JS; Wan L; Chen SY; Huang YC; Chan C; Chiu IW; Tsai FJ
Int J Immunogenet; 2010 Dec; 37(6):487-92. PubMed ID: 20618517
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between fibrinogen Bß-148C/T polymorphism and coronary artery lesions in children with Kawasaki disease].
Gao J; Wang HY; Wu NJ; Zhang SH
Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jul; 12(7):518-20. PubMed ID: 20637145
[TBL] [Abstract][Full Text] [Related]
6. Genetic variations of HLA-DRB1 and susceptibility to Kawasaki disease in Taiwanese children.
Huang FY; Chang TY; Chen MR; Hsu CH; Lee HC; Lin SP; Kao HA; Chiu NC; Chi H; Liu TY; Liu HF; Dang CW; Chu CC; Lin M; Sung TC; Lee YJ
Hum Immunol; 2007 Jan; 68(1):69-74. PubMed ID: 17207714
[TBL] [Abstract][Full Text] [Related]
7. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease.
Ikeda K; Ihara K; Yamaguchi K; Muneuchi J; Ohno T; Mizuno Y; Hara T
Pediatr Res; 2008 Feb; 63(2):182-5. PubMed ID: 18091353
[TBL] [Abstract][Full Text] [Related]
8. HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms.
Lin YJ; Wan L; Wu JY; Sheu JJ; Lin CW; Lan YC; Lai CH; Hung CH; Tsai Y; Tsai CH; Lin TH; Lin JG; Hsueh KC; Huang YM; Chang JS; Tsai FJ
Arthritis Rheum; 2009 Feb; 60(2):604-10. PubMed ID: 19180512
[TBL] [Abstract][Full Text] [Related]
9. The -590 C/T and 8375 A/G interleukin-4 polymorphisms are not associated with Kawasaki disease in Taiwanese children.
Huang FY; Chang TY; Chen MR; Lee HC; Chiu NC; Chi H; Hsu CH; Lin SP; Liu HF; Chen WF; Chu CC; Lin M; Lee YJ
Hum Immunol; 2008 Jan; 69(1):52-7. PubMed ID: 18295676
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor gene haplotypes in Kawasaki disease.
Breunis WB; Biezeveld MH; Geissler J; Ottenkamp J; Kuipers IM; Lam J; Hutchinson A; Welch R; Chanock SJ; Kuijpers TW
Arthritis Rheum; 2006 May; 54(5):1588-94. PubMed ID: 16645995
[TBL] [Abstract][Full Text] [Related]
11. ITPKC gene SNP rs28493229 and Kawasaki disease in Taiwanese children.
Chi H; Huang FY; Chen MR; Chiu NC; Lee HC; Lin SP; Chen WF; Lin CL; Chan HW; Liu HF; Huang LM; Lee YJ
Hum Mol Genet; 2010 Mar; 19(6):1147-51. PubMed ID: 20045869
[TBL] [Abstract][Full Text] [Related]
12. Influence of interleukin 18 promoter polymorphisms in susceptibility to Kawasaki disease in Taiwan.
Hsueh KC; Lin YJ; Chang JS; Wan L; Tsai YH; Tsai CH; Tsai FJ
J Rheumatol; 2008 Jul; 35(7):1408-13. PubMed ID: 18484687
[TBL] [Abstract][Full Text] [Related]
13. Tissue inhibitor of metalloproteinase 2 and coronary artery lesions in Kawasaki disease.
Furuno K; Takada H; Yamamoto K; Ikeda K; Ohno T; Khajoee V; Mizuno Y; Hara T
J Pediatr; 2007 Aug; 151(2):155-60, 160.e1. PubMed ID: 17643768
[TBL] [Abstract][Full Text] [Related]
14. [Expression of monocyte chemotactic protein-1 in peripheral blood mononuclear cells of children with Kawasaki disease and its relation to coronary artery impairment].
Zhang J; Gui YH; Yang Y
Zhonghua Er Ke Za Zhi; 2008 Feb; 46(2):132-5. PubMed ID: 19099689
[TBL] [Abstract][Full Text] [Related]
15. Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.
Park JA; Shin KS; Kim YW
J Korean Med Sci; 2005 Aug; 20(4):607-11. PubMed ID: 16100452
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency of alleles associated with elevated tumor necrosis factor-alpha levels in children with Kawasaki disease.
Quasney MW; Bronstein DE; Cantor RM; Zhang Q; Stroupe C; Shike H; Bastian JF; Matsubara T; Fujiwara M; Akimoto K; Newburger JW; Burns JC
Pediatr Res; 2001 May; 49(5):686-90. PubMed ID: 11328953
[TBL] [Abstract][Full Text] [Related]
17. Major histocompatibility complex class I chain-related gene polymorphisms: associated with susceptibility to Kawasaki disease and coronary artery aneurysms.
Hsieh YY; Chang CC; Hsu CM; Chen SY; Lin WH; Tsai FJ
Genet Test Mol Biomarkers; 2011 Nov; 15(11):755-63. PubMed ID: 21815799
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
[TBL] [Abstract][Full Text] [Related]
19. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement.
Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F
J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708
[TBL] [Abstract][Full Text] [Related]
20. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
Ahn JG; Bae Y; Shin D; Nam J; Kim KY; Kim DS
Rheumatology (Oxford); 2019 May; 58(5):770-775. PubMed ID: 30535242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
